laitimes

Drug progress and challenges in treating COVID-19 and its variant infections: Today, two years after the pandemic, drugs to treat COVID-19 infection or COVID-19 are entering the clinic at an unprecedented rate

Drug progress and challenges in treating COVID-19 and its variant infections: Today, two years after the pandemic, drugs treating COVID-19 infection or COVID-19 are entering clinical trials to validate antiviral therapies and experimental applications at an unprecedented rate. Both traditional Chinese medicine and Western antiviral therapy are believed to be able to clearly improve the prognosis of new crown pneumonia or infected people, especially early medication and early treatment. The latest report summarizes the successes and challenges of Western medicine antiviral therapy

Drug progress and challenges in treating COVID-19 and its variant infections: Today, two years after the pandemic, drugs to treat COVID-19 infection or COVID-19 are entering the clinic at an unprecedented rate
Drug progress and challenges in treating COVID-19 and its variant infections: Today, two years after the pandemic, drugs to treat COVID-19 infection or COVID-19 are entering the clinic at an unprecedented rate
Drug progress and challenges in treating COVID-19 and its variant infections: Today, two years after the pandemic, drugs to treat COVID-19 infection or COVID-19 are entering the clinic at an unprecedented rate

Read on